BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Menlo Therapeutics Initiates Enrollment in Phase II Clinical Trial with Serlopitant for Refractory Chronic Cough

  Menlo Therapeutics has initiated enrollment in a 170-subject Phase II trial evaluating serlopitant as a treatment for refractory chronic cough.

  October 26, 2017

   · 

  2 min read
• FDA

  Paraflu Assay Now FDA Cleared on Hologic’s New Panther Fusion System

  Hologic announced today that it has received 510(k) clearance from the FDA for its Panther Fusion Paraflu assay, a multiplexed assay which runs on the new Panther Fusion system.

  October 26, 2017

   · 

  3 min read
• Drug Development

  Syros’ Drug Discovery Research in Immuno-Oncology Highlighted in Oral Presentation at American College of Surgeons Clinical Congress

  Syros today announced that it has identified alterations in regulatory regions of the genome in immune, tumor and stromal cells isolated from pancreatic cancer patient tumors, leading to the identification of new drug targets.

  October 26, 2017

   · 

  7 min read
• Deals

  Factory CRO Acquires MileStone Research Organization, Builds North American Presence

  Factory CRO, a leading global contract research organization focused on medical devices and IVDs, has announced the acquisition of MileStone Research Organization.

  October 26, 2017

   · 

  2 min read
• Drug Development

  Protalex Announces Publication in the British Journal of Haematology Supporting the Potential of PRTX-100 to Treat Immune Thrombocytopenia

  Protalex announces that preclinical data showing its lead drug candidate PRTX-100 increases blood platelet counts in a murine model of immune thrombocytopenia (ITP) were published in the recent issue of the peer-reviewed journal, British Journal of Haematology.

  October 26, 2017

   · 

  5 min read
• Business

  Arcadia Biosciences Announces Date of Third-Quarter 2017 Financial Results and Business Highlights Conference Call

  Arcadia Biosciences today announced its plan to release its third-quarter 2017 financial and business results after market close on November 9, 2017.

  October 26, 2017

   · 

  1 min read
• Policy

  Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton Gel

  Perrigo today announced that it has settled the Hatch-Waxman litigation relating to Onexton Gel brought by Valeant and Dow Pharma Sciences.

  October 26, 2017

   · 

  4 min read
• Business

  Harpoon Therapeutics Expands Management Team

  Harpoon Therapeutics announced today that it has appointed Susan Dana Jones, Ph.D., to the position of senior vice president, product development and Rachael Lester to VP, corporate development.

  October 26, 2017

   · 

  3 min read
• Drug Development

  Heron Therapeutics Granted FDA Fast Track Designation for HTX-011 to Reduce Postoperative Pain and the Need for Opioid Analgesics for 72 Hours

  Heron Therapeutics announced today that the FDA has granted Fast Track designation to the Company’s investigational agent, HTX-011, for local administration into the surgical site to reduce postoperative pain and the need for opioid analgesics for 72 hours.

  October 26, 2017

   · 

  5 min read
• FDA

  Nitiloop Snags FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro Catheter

  Nitiloop received FDA clearance for its new Nova Cross Extreme and Nova Cross BTK.

  October 26, 2017

   · 

  1 min read